Juliana Eng

Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

Sean M. McBride, Eric J. Sherman, C. Jillian Tsai et al. · Journal of Clinical Oncology · 2020 · 382 citations · Full text

COVID-19 in patients with lung cancer

Jie Luo, Hira Rizvi, Isabel R. Preeshagul et al. · Annals of Oncology · 2020 · 267 citations · Full text

Medicine, Covid-19 Pandemic, Covid-19 Epidemiology +3

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

C. Jillian Tsai, Jonathan T. Yang, Narek Shaverdian et al. · The Lancet · 2023 · 214 citations · Full text

Adaptive Radiotherapy, Radiation Therapy, Medicine +9

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Justin Jee, Emily S. Lebow, Randy Yeh et al. · Nature Medicine · 2022 · 170 citations · Full text

Tumor Dna-guided Therapy, Overall Survival, Medicine +7

Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas

Juliana Eng, Kaitlin M. Woo, Camelia S. Sima et al. · Journal of Thoracic Oncology · 2015 · 105 citations · Full text

Oncogenic Agent, Medicine, Concurrent Pik3ca Mutations +9